Mendus AB (publ) (IMMU) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.037x

Based on the latest financial reports, Mendus AB (publ) (IMMU) has a cash flow conversion efficiency ratio of -0.037x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-20.80 Million ≈ $-2.24 Million USD) by net assets (Skr565.14 Million ≈ $60.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Mendus AB (publ) defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Mendus AB (publ) - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how Mendus AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Mendus AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mendus AB (publ) ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Ananda Development Public Company Limited BK:ANAN	0.067x
Insung Information Co. Ltd KQ:033230	-0.098x
Danen Technology Corp TW:3686	-0.001x
PESTECH International Bhd KLSE:5219	-0.161x
FOODWELL Co. Ltd KQ:005670	0.092x
01 Communique Laboratory Inc V:ONE	-0.106x
Ekso Bionics Holdings Inc NASDAQ:EKSO	-0.370x
Navamedic ASA OL:NAVA	0.077x

Annual Cash Flow Conversion Efficiency for Mendus AB (publ) (2010–2025)

The table below shows the annual cash flow conversion efficiency of Mendus AB (publ) from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see Mendus AB (publ) (IMMU) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr585.07 Million ≈ $62.96 Million	Skr-81.53 Million ≈ $-8.77 Million	-0.139x	-12.85%
2024-12-31	Skr645.15 Million ≈ $69.43 Million	Skr-79.67 Million ≈ $-8.57 Million	-0.123x	+46.53%
2023-12-31	Skr704.73 Million ≈ $75.84 Million	Skr-162.76 Million ≈ $-17.52 Million	-0.231x	-8.67%
2022-12-31	Skr514.44 Million ≈ $55.36 Million	Skr-109.33 Million ≈ $-11.77 Million	-0.213x	-1.12%
2021-12-31	Skr656.74 Million ≈ $70.68 Million	Skr-138.03 Million ≈ $-14.85 Million	-0.210x	-145.38%
2020-12-31	Skr661.09 Million ≈ $71.14 Million	Skr-56.63 Million ≈ $-6.09 Million	-0.086x	+83.98%
2019-12-31	Skr272.78 Million ≈ $29.36 Million	Skr-145.81 Million ≈ $-15.69 Million	-0.535x	-107.36%
2018-12-31	Skr406.04 Million ≈ $43.70 Million	Skr-104.67 Million ≈ $-11.26 Million	-0.258x	-5.20%
2017-12-31	Skr189.56 Million ≈ $20.40 Million	Skr-46.45 Million ≈ $-5.00 Million	-0.245x	+25.64%
2016-12-31	Skr102.39 Million ≈ $11.02 Million	Skr-33.74 Million ≈ $-3.63 Million	-0.330x	-14.00%
2015-12-31	Skr139.18 Million ≈ $14.98 Million	Skr-40.23 Million ≈ $-4.33 Million	-0.289x	+53.42%
2014-12-31	Skr64.63 Million ≈ $6.95 Million	Skr-40.10 Million ≈ $-4.32 Million	-0.621x	-570.22%
2013-12-31	Skr100.24 Million ≈ $10.79 Million	Skr-9.28 Million ≈ $-998.77K	-0.093x	+68.12%
2012-12-31	Skr24.60 Million ≈ $2.65 Million	Skr-7.15 Million ≈ $-769.03K	-0.290x	+31.50%
2011-12-31	Skr7.63 Million ≈ $820.73K	Skr-3.23 Million ≈ $-347.98K	-0.424x	+0.26%
2010-12-31	Skr3.92 Million ≈ $421.83K	Skr-1.67 Million ≈ $-179.31K	-0.425x	--

About Mendus AB (publ)

ST:IMMU Sweden Biotechnology

Market Cap

$41.55 Million

Skr386.09 Million SEK

Market Cap Rank

#22632 Global

#428 in Sweden

Share Price

Skr6.30

Change (1 day)

+14.55%

52-Week Range

Skr3.96 - Skr10.02

All Time High

Skr737.49